Late-onset Mycobacterium abscessus sepsis in a very low birthweight premature infant: Diagnostic and therapeutic challenges

American Journal of Perinatology

Volumn 21, Issue 6, 2004, Pages 365-368

  Di Pentima, M Cecilia ^a   Doyle, Robin ^a   Locke, Robert ^a   Tuttle, Deborah ^a  

^a NEMOURS ALFRED I DUPONT HOSPITAL FOR CHILDREN   (United States)

Author keywords

Mycobacterium abscessus; Prematurity; Sepsis

Indexed keywords

AMIKACIN; CEFOXITIN; CIPROFLOXACIN; CLARITHROMYCIN; DOXYCYCLINE; SULFAMETHOXAZOLE; SULTAMICILLIN; TOBRAMYCIN;

ANTIBIOTIC SENSITIVITY; APGAR SCORE; ARTICLE; BACTERIUM CULTURE; BLOOD CULTURE; CASE REPORT; CESAREAN SECTION; DISEASE COURSE; FEMALE; FERTILIZATION IN VITRO; HUMAN; LUNG HYPOPLASIA; MYCOBACTERIUM ABSCESSUS; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN; NEWBORN SEPSIS; ONSET AGE; PATENT DUCTUS ARTERIOSUS; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURITY; PRENATAL SCREENING; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; VERY LOW BIRTH WEIGHT;

BACTEREMIA; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE, DISEASES; INFANT, VERY LOW BIRTH WEIGHT; LUNG ABSCESS; MYCOBACTERIA, ATYPICAL; MYCOBACTERIUM CHELONAE; MYCOBACTERIUM INFECTIONS, ATYPICAL; TIME FACTORS; TREATMENT OUTCOME;

EID: 4243063945     PISSN: 07351631     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-831885     Document Type: Article

References (12)

1. Speert DP, Munson D, Mitchell C, et al. Mycobacterium chelonei septicemia in a premature infant. J Pediatr 1980; 96:681-683
2. Tashjian JH, Coulam CB, Washington JA II. Vaginal flora in asymptomatic women. Mayo Clin Proc 1976;51:557-561
3. Phillips MS, von Reyn CF. Nosocomial infections due to nontuberculous mycobacteria. Clin Infect Dis 2001;33: 1363-1374
4. Kusunoki S, Ezaki T. Proposal of Mycobacterium pereginum sp. nov., nom. rev., and elevation of Mycobacterium chelonae subsp. abscessus (Kubica et al.) to species status: Mycobacterium abscessus comb. nov. Int J Syst Bacteriol 1992;42:240-245
5. Yakrus MA, Hernandez SM, Floyd MM, Sikes D, Butler WR, Metchock B. Comparison of methods for identification of Mycobacterium abscessus and M. chelonae isolates. J Clin Microbiol 2001;39:4103-4110
6. Brown BA WR. Infections due to nontuberculous Mycobacteria. In: Mandell GL BJ, Dolin R, eds. Principles and Practice of Infectious Diseases. Vol. II. Philadelphia: Curchill Livingstone; 2000:2631-2636
7. Brown-Elliott BA, Wallace RJ Jr. Clarithromycin resistance to Mycobacterium abscessus. J Clin Microbiol 2001; 39:2745-2746
8. Brown BA, Wallace RJ Jr, Onyi GO, De Rosas V, Wallace RJ III. Activities of four macrolides, including clarithromycin, against Mycobacterium fortuitum, Mycobacterium chelonae, and M. chelonae-like organisms. Antimicrob Agents Chemother 1992;36:180-184
9. Woods GL, Brown-Elliot BA, Desmond EP, et al. Susceptibility testing of Mycobacteria, Nocardiae, and other aerobic actinomycetes; approved standard Wayne, PA: National Committee for Clinical Laboratory Standards; 2003:25-37
10. Fernandez-Roblas R, Esteban J, Cabria F, Lopez JC, Jimenez MS, Soriano F. In vitro susceptibilities of rapidly growing mycobacteria to telithromycin (HMR 3647) and seven other antimicrobials. Antimicrob Agents Chemother 2000;44:181-182
11. Brown-Elliott BA, Wallace RJ Jr, Crist CJ, Mann L, Wilson RW. Comparison of in vitro activities of gatifloxacin and ciprofloxacin against four taxa of rapidly growing mycobacteria. Antimicrob Agents Chemother 2002;46:3283-3285
12. Wallace RJ Jr, Brown-Elliott BA, Crist CJ, Mann L, Wilson RW. Comparison of the in vitro activity of the glycylcydine tigecycline (formerly GAR-936) with those of tetracycline, minocycline, and doxycydine against isolates of nontuberculous mycobacteria. Antimicrob Agents Chemother 2002;46:3164-3167